Mahesh Kudari

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency

Donald B. Kohn, Claire Booth, Kit L. Shaw et al. · New England Journal of Medicine · 2021 · 218 citations · Full text

Life Sciences, Immunology, Molecular Medicine +12

FDXR is a biomarker of radiation exposure in vivo

Gráinne O’Brien, Lourdes Cruz-Garcia, Matthäus Majewski et al. · Scientific Reports · 2018 · 120 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID

Heide A. Stirnadel-Farrant, Mahesh Kudari, Nadia Garman et al. · Orphanet Journal of Rare Diseases · 2018 · 41 citations · Full text

Medicine, Hematology, Translational Sciences +17

A psychological comparison of temporomandibular disorder and chronic daily headache: are there targets for therapeutic interventions?

Waseem Jerjes, Geir Madland, Charlotte Feinmann et al. · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · 2006 · 26 citations

Dentistry, Psychology, Temporomandibular Disorders +14

Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Results in an Expanded Cohort

Donald B. Kohn, Kit L. Shaw, Elizabeth Garabedian et al. · Blood · 2019 · 16 citations

Pharmacy, Hematology, Immunology +16